From Medscape Oncology

Coverage from the

17th World Conference on Lung Cancer (WCLC)

December 04 - 07, 2016; Vienna, Austria

December 04 - 07, 2016 Vienna, Austria

WCLC e-Cigarettes Not the Panacea They Are Claimed to Be The use of electronic cigarettes as an aid to smoking cessation may be exposing individuals to increased health risks resulting from unregulated chemical additives, warns a leading expert.
Medscape Medical News, December 6, 2016
WCLC Osimertinib 'Officially Standard of Care' in T790M-Mutated NSCLC The third-generation EGFR-TKI osimertinib more than doubles progression-free survival in NSCLC, making it the standard of care in T790M-positive lung cancer, say experts.
Medscape Medical News, December 6, 2016

Conference News

WCLC Underserved Populations 'Left Out of Lung Cancer Screening'
Medscape Medical News, December 21, 2016
WCLC Icotinib Doubles PFS in NSCLC Patients With Brain Metastases
Medscape Medical News, December 20, 2016
WCLC Path Labs 'Can Produce PD-L1 Tests to Match Standard Assays'
Medscape Medical News, December 20, 2016
WCLC Exceptional SCLC Survivors: 5-Year Median Survival
Medscape Medical News, December 20, 2016
WCLC Patient Choice and Monitoring Are 'Key to NSCLC Immunotherapy'
Medscape Medical News, December 12, 2016

WCLC Pembrolizumab 1st-Line in NSCLC Also Boosts Quality of Life
Medscape Medical News, December 8, 2016
WCLC Immunotherapy Looks 'Promising' in Malignant Mesothelioma
Medscape Medical News, December 7, 2016
WCLC e-Cigarettes Not the Panacea They Are Claimed to Be
Medscape Medical News, December 6, 2016
WCLC Osimertinib 'Officially Standard of Care' in T790M-Mutated NSCLC
Medscape Medical News, December 6, 2016

Most Popular News from WCLC 2015

Lung Cancer Rates Surging in Never-Smokers Rates of lung cancer are increasing steadily in people who have never smoked, according to two new studies.
Medscape Medical News, Sep 9, 2015
NSCLC Patients With Brain Mets Often Excluded From Trials Patients with brain metastases are often excluded from clinical trials, especially from those sponsored by industry.
Medscape Medical News, Sep 17, 2015
Delays in Cancer Drug Approvals Cost Lives The current regulatory process for new anticancer therapies slows progress by increasing drug developments costs, according to a new study.
Medscape Medical News, Sep 8, 2015

Medscape Oncology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Medscape Board at the Podium

Corey Langer, MD
University of Pennsylvania, Philadelphia
Presentation: New Challenges for Lung Cancer: Waterpipes and E-Cigarettes
Date: December 5, 2016
Presentation: WCLC 2016 Scientific Highlights
Date: December 7, 2016

Previous Coverage

Related Resource

Lung Cancer News & Perspectives